Pfizer · NSE: PFIZER · BSE: 500680
Q4 FY19 results · Jan–Mar 2019
Pfizer reported revenue from operations of ₹535.66 crore and net profit of ₹109.47 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 535.66 | — | — | 513.79 | +4.3% |
| Other income | 35.45 | — | — | 64.35 | −44.9% |
| Total income | 571.11 | — | — | 578.14 | −1.2% |
| Profit before tax | 168.22 | — | — | 200.62 | −16.1% |
| Net profit for the period | 109.47 | — | — | 131.94 | −17.0% |
| EPS, basic (₹) | 23.93 | — | — | 28.84 | −17.0% |
| Net margin (%) | 20.4 | — | 25.7 |
Standalone
- Filed with BSE
- 28 May 2019, 18:14 IST
- Board meeting
- 28 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE